All Clinical Trials

Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE)

Pediatric Dose Optimization for Seizures in EMS (PediDOSE)

  • Not accepting healthy volunteers
  • UTSW Principal Investigator: GEOFFREY SCOTT LOWE

summary

The Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study is an emergency medicine study designed to evaluate if a standardized method for paramedics to administer seizure medication leads to timely delivery of the right dose. The purpose of this study is to simplify how paramedics give medication to seizing children to stop the seizure and to decrease the number of children still seizing when they arrive at the emergency department. By replacing complicated dose calculations with age-based standardized dosing, we aim to increase the number of children who receive the right amount of seizure-stopping treatment before arriving at the hospital.

objective

The overall objective of the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) study is to measure the impact of standardized EMS midazolam dosing on seizure treatment effectiveness and safety.

eligibility

  • Age ≥ 6 months* to ≤ 13 years; AND

  • Witnessed by paramedic to be actively seizing, regardless of seizure type or duration; AND

  • Under the care of a paramedic; AND

  • Transported by an EMS agency participating in this study.

If you are interested in this clinical trial, please contact Elizabeth Hernandez on the Children’s Health Research Team.Call 214-456-2915Email